2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Psychomotor Disorders: new trials by email Literature Review of Psychomotor Disorders trials Research Report on Psychomotor Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care Dexmedetomidine Hydrochloride - Hyperactive Delirium, Delirium of Mixed Origin | Phase 1 / Phase 2 | Unknown | Bruyère Health Research Institute. | 50 | 2024-01-30 | 2025-04-15 |
| Study of Depakote for Behavioral and Psychological Symptoms in Dementia Depakote - Dementia | Phase 1 | Unknown | Hearthstone Alzheimer Care | 20 | 2004-03-01 | 2006-08-15 |
Psychomotor Agitation (2) · Behavior (1) · Behavioral Symptoms (1) · Death (1) · Delirium (1) · Dementia (1)
Aberrant Motor Behavior in Dementia (2) · Dyskinesias (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurocognitive Disorders (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Behavior (1) · Behavioral Symptoms (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Confusion (1)
Dexmedetomidine (1) · Valproic Acid (1)
Bruyère Health Research Institute. (1) · Hearthstone Alzheimer Care (1)
Canada (1) · United States (1)
James Downar, MDCM, MSc (1) · Mark Vanelli, MD (1)